The European Union granted Pulmatrix Inc. (Nasdaq: PULM) a patent for its inhaled drug delivery technology iSPERSE sending the stock price soaring $1.10 to close at $3.88.
EU grants patent to Pulmatrix
March 21, 2017 at 18:16 PM EDT
EU grants patent to PulmatrixMarch 21, 2017 at 18:16 PM EDT
The European Union granted Pulmatrix Inc. (Nasdaq: PULM) a patent for its inhaled drug delivery technology iSPERSE sending the stock price soaring $1.10 to close at $3.88. Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|